Document:

<PAGE>

                                                                   EXHIBIT 10.32

                               SUPPLY AGREEMENT

                                by and between

                        Tactical Fabs, Inc. ("Seller")
                               51 Whitney Place
                              Freemont, CA 94539

                                      and

                           SEQUENOM, Inc. ("Buyer")
                           11555 Sorrento Valley Rd
                           San Diego, CA 92121-1331

This Agreement dated April 1, 1999 (the "Execution Date") is by and between
SEQUENOM, Inc., a corporation organized and existing under the laws of the State
of California and having its principal office at 11555 Sorrento Valley Road, San
Diego, California 92121-1331 ("Buyer"), and Tactical Fabs, Inc., a corporation
organized and existing under the laws of the State of California and having its
principal office at 51 Whitney Place, Fremont, CA 94539 ("Seller").

                                 INTRODUCTION

The parties agree that the Seller shall design, manufacture and supply chips
("DIE") as specified by Buyer under this Agreement.  Seller and Buyer in
addition agree to work cooperatively to further pursue the development of DIE
for applications in mass spectrometry.

NOW, THEREFORE, in consideration of the foregoing premises and the mutual
promises and covenants set forth below, Seller and Buyer mutually agree as
follows:

                            Article 1.  DEFINITIONS

When used in this Agreement, each of the following, terms shall have the
meanings set forth in this Article I:

SECTION 1.1    "Affiliate" means any corporation, company, partnership, joint
venture and/or firm which controls, is controlled by, or is under common control
with a specified person or entity.  For purposes of this Section 1.1, "control"
shall mean (a) in the case of corporate entities, direct or indirect ownership
of at least fifty percent (50%) of the stock or shares having the right to vote
for the election of directors, and (b) in the case of non-corporate entities,
direct or indirect ownership of at least fifty percent (50%) of the equity
interest with the power to direct the management and policies of such non-
corporate entities.

Confidential                        Page 1
<PAGE>

SECTION 1.2    "Agreement" shall mean this Supply Agreement, as amended from
time to time.

SECTION 1.3    "Delivery Date" shall mean a date for which delivery of Product
is properly requested in a purchase order.

SECTION 1.4    "Initial Term" shall have the meaning set forth in Section 5. 1.

SECTION 1.5    "Party" means Buyer or Seller; "Parties" means Buyer and Seller.
As used in this Agreement, references to "third parties" do not include a Party
or its Affiliates.

SECTION 1.6    "Product" shall mean each product supplied hereunder by Seller in
its completed and functional form and that is listed in and meets in all
material respects the specifications set forth in Exhibit I, attached hereto and
made a part hereof, as such Exhibit is amended by the parties from time to time.

SECTION 1.7    "Change of Control" means a merger, consolidation, sale or other
transfer of all or substantially all of the assets of either Party to a third
party.

SECTION 1.8    "Confidential Information" means all materials, know-how or other
information, including, without limitation, proprietary information and
materials (whether or not patentable) regarding a Party's technology, products,
business information or objectives, which is designated as confidential in
writing by the disclosing Party, whether by letter or by the use of an
appropriate stamp or legend, prior to or at the time any such material, trade
secret or other information is disclosed by the disclosing Party to the other
Party.  Notwithstanding the foregoing to the contrary, materials, know-how or
other information which is orally, electronically or visually disclosed by a
Party, or is disclosed in writing without an appropriate letter, stamp or
legend, shall constitute Confidential Information of a Party (a) if the
disclosing Party, within thirty (30) days after such disclosure, delivers to the
other Party a written document or documents describing the materials, know-how
or other information and referencing the place and date of such oral, visual,
electronic or written disclosure and the names of the persons to whom such
disclosure was made, or (b) such information is of the type that is customarily
considered to be confidential information by persons engaged in activities that
are substantially similar to the activities being engaged in by the Parties
hereunder.  Notwithstanding the foregoing, any technical or financial
information of a Party disclosed at a meeting of Seller and the Buyer or
disclosed through an audit or royalty reports shall constitute Confidential
Information of a Party unless otherwise specified.

SECTION 1.9    "Executive Officers" means the Chief Executive Officer of Buyer
(or an executive of Buyer designated by such Chief Executive Officer) and the
Chief Executive Officer of Seller (or an officer of Seller designated by such
Chief Executive Officer).

SECTION 1.10   ADDITIONAL DEFINITIONS.  Each of the following definitions set
forth in the section of this Agreement indicated below:

DEFINITION SECTION

Confidential                                                                   2
<PAGE>

"Breaching Party" "Extension Period" "Intellectual Property" "Non-Breaching
Party" "Notification" "Response Period" "Software Developments" "Specified
Process Technology" "Termination Date" "Backorder"

                   Article 2. SALE AND PURCHASE OF PRODUCTS

SECTION 2.1    SALE AND PURCHASE.  Seller, within the limitations contained in
this Article, agrees to exclusively sell to Buyer such quantities of Product as
Buyer may order in accordance herewith.  Subject to the provisions of Section
4.1 and 5.1 hereof, so long as this Agreement shall remain in effect, Buyer
agrees, for itself, its Affiliates and sublicensees, to satisfy solely through
Buyer's purchase of Products under this Agreement   ***   of Buyer's and Buyer's
Affiliates' and sublicensees' requirements of Product or any other products with
the characteristics that meet the specifications as described in Exhibit I
("Requirements").

It is understood that Seller shall have the right in connection with supply
hereunder to subcontract with third parties as Seller deems advisable to
manufacture Product, provided, however, that Seller shall remain fully
responsible hereunder and the subcontractors are bound by the terms and
conditions hereunder.

SECTION 2.2    QUANTITY; FORECASTS.

A.   Buyer and Seller will mutually agree within thirty (30) days of signing
     this Agreement, an initial order volume and the first delivery date.  Buyer
     at this time will provide a reasonable best estimate of the next three
     quarter's forecast for the Product.

B.   Commencing on the second year of this Agreement, Buyer will provide Seller
     a forecast of Buyer's quantity requirements for such Product for at least
     the next four (4) full calendar quarters.  Thereafter, Buyer shall deliver
     to Seller at or prior to the end of each calendar quarter, Buyer's firm
     order for such Product for the second calendar quarter following such
     calendar quarter and a forecast of its quantity requirements for such
     Product for the three (3) following calendar quarters.

C.   Commencing in the second year of this Agreement, the amount of any Product
     forecasted for delivery in the first of the three calendar quarters
     forecasted of year two of this Agreement shall be ***
          *** of the most recent previous forecast for such a quarter.

D.   After the first year of this Agreement the total amount of each Product
     ordered by Buyer for delivery in any calendar quarter for which an order is
     required may  ***
          **     of Buyer's most recent forecast of its requirements for
     such Product for such quarter. In addition, Seller's supply obligation will
     not extend    ***
          ***     of Buyer's most recent forecast of its requirements for
     such

     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential
                                                                               3
<PAGE>

     Product for such quarter. If a Buyer Product requirement for any quarter
     exceeds *** of Buyer's most recent forecast of it requirements for such
     Product for such calendar quarter, Seller and Buyer will discuss in good
     faith the additional amount, if any, that Seller is willing to supply
     consistent with its other obligations and Buyer will adjust its order
     accordingly. Buyer shall indemnify Seller and reimburse it promptly upon
     request for all reasonable out of pocket costs and expenses, including the
     cost of carrying increased inventory, to the extent caused by any deviation
     in order quantities from the limits imposed by the preceding sentence, and
     Seller will act reasonably to mitigate any such costs and expenses.

SECTION 2.3    TECHNOLOGY CHANGE

        *

SECTION 2.4    BACKORDERS.

A.   Backorders are defined as orders that have not been fully received at the
     Buyer within the guaranteed order lead time.

B.   Backorders must show an approximate shipping date and indicate the reason
     for such backorder.

C.   The Seller is required to provide any backorders without service or
     delivery charges.

D.   It is the responsibility of the Seller to manage backorders and provide the
     Buyer, at no additional cost, with required product to ensure stock-outs do
     not occur.

E.   The Seller will be in default if the Product is backordered for more than
     ten (10) working days, or if the Buyer feels that the approximate shipping
     date provided by the Seller for the backordered Product(s) jeapordizes the
     Buyer's commercial operations and the operation of its Customers.

     (i)  In case of default, and after notifying the Seller, Buyer may obtain
          the same quantity of the Product from other suppliers.

     (ii) The Seller will be responsible, for the cost difference between the
          Product and the Product from other suppliers.

SECTION 2.5    DELIVERY.

A.   Delivery will be Free On Board (FOB) the Buyer's receiving dock and will
     include delivery, packaging, and unloading costs.  The Buyer will not
     assume any of these costs.

     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential
                                                                               4

<PAGE>

B.      Include all costs in the quoted unit price.

*    Seller agrees the terms of this Agreement may be renegotiated upon written
     notice from Buyer, with such renegotiated terms to take effect no sooner
     than 90 days after such initial notice from Seller to Buyer, if, in the
     opinion of the Buyer, the Product provided by the Seller has been displaced
     by other technologies; provided however, Buyer shall afford Seller a
     reasonable opportunity to supply alternative technology.

C.      Seller will package the Products in accordance with the specifications
        set forth in Exhibit I hereto. Seller will include with each shipment
        copies of all applicable quality and testing records.

SECTION 2.6    REJECTION OF PRODUCT IN CASE OF NONCONFORMITY.

A.      Buyer may reject any portion of shipment of Product that does not
        conform to the specifications contained in Exhibit I. In order to reject
        a shipment, Buyer must (i) give notice to Seller of Buyer's intent to
        reject the shipment within ten (10) days of receipt together with a
        detailed written indication of the reasons for such possible rejection,
        and (ii) as promptly as reasonably possible thereafter, provide Seller
        with notice of final rejection and the full basis thereof. After notice
        of intent to reject is given, Buyer shall cooperate with Seller in
        determining whether rejection is necessary or justified. If no such
        notice of intent to reject is timely received, Buyer shall be deemed to
        have accepted such delivery of Product, provided, however, in the case
        of Products having latent defects which upon diligent examination by
        Buyer could not have been discovered, Buyer must give notice of Buyer's
        intent to reject within thirty (30) days after discovery of such
        defects, provided that such notice may in no event be given later than
        ninety (90) days after receipt of the shipment. In any event, Buyer
        shall pay for the shipment as otherwise provided herein and shall be
        entitled to a refund of the purchase price (together with insurance and
        freight charges if applicable) of properly rejected Products at the time
        they are ultimately rejected. Seller shall notify Buyer as promptly as
        reasonable possible whether it accepts Buyer's basis for any rejection.

B.      Whether or not Seller accepts Buyer's basis for rejection, promptly on
        receipt of a notice of rejection, Seller shall use its reasonable
        efforts, at Buyer's request to provide replacement Product which shall
        be purchased by Buyer as provided in this Agreement.

C.      Unless Seller requests the return of the rejected batch within sixty
        (60) days of receipt of buyer's notice of rejection, Buyer shall destroy
        such batch promptly and provide Seller with certification of such
        destruction. Buyer shall, upon receipt of Seller's request for return,
        promptly dispatch said batch to Seller, at Seller's cost.

                         Article 3. PRICE AND PAYMENTS

SECTION 3.1    PRICE.  The price Buyer shall pay to Seller for Product purchased
hereunder is as indicated in Exhibit II. Prices shall be negotiated on a annual
basis between the two parties with price negotiations commencing no later than
three (3) months prior to the

Confidential                                                                   5
<PAGE>

anniversary date and completed no later than two (2) months prior to the
anniversary date of this Agreement.

SECTION 3.2    Prices quoted in Exhibit II are net costs, in United States
dollars.  Federal Tax and State Sales Tax extra, where applicable.  Duty and
brokerage costs, if applicable are to be included in unit prices.

SECTION 3.3    CURRENCY AND METHOD OF PAYMENTS; LATE PAYMENTS.  All payments
under this Agreement shall be made in United States dollars by wire transfer to
such bank account as Seller may designate from time to time within no more than
ten (10) days when such payment is due. Buyer shall pay interest to Seller on
the aggregate amount of any payments that are not paid on or before the date
such payments are due under this Agreement at a rate per annum equal to ***
as reported by Seller's bank from time to time calculated on the number of days
such payment is delinquent.

                      ARTICLE 4.  ANNUAL BUSINESS REVIEW

SECTION 4.1    Within thirty (30) days of the anniversary date of this Agreement
both Parties shall meet to review the performance of each party under this
Agreement and if necessary outline steps to improve performance.

                        Article 5. PARTIAL TERMINATION

SECTION 5.1    TERMINATION OF PURCHASE OBLIGATIONS; FAILURE TO DELIVER.  In
addition to any termination of this Agreement under Article 6 hereof, this
Agreement shall terminate as to a particular Product as follows:

A.   If at any time after the Initial Term (as defined in Section 5.1) Buyer
     notifies Seller that Buyer has received a written good faith firm quote
     from a reputable third party supplier of recognized standing (other than an
     Affiliate) to supply Buyer for a period of
                                   ***
                                   ***       Seller shall have sixty (60) days
     after receipt of such notice to notify Buyer that Seller intends or does
     not intend to reduce its then applicable transfer price of such Product to
     a price       ***
          ***      upon the expiration of such sixty (60) day period. If Seller
     fails to give such notice or notifies Buyer that it does not intend to so
     reduce its then applicable transfer price of such Product, Buyer may, upon
     thirty (30) days' prior notice to Seller, elect to terminate its
     obligations hereunder to purchase, and Seller's obligations to supply, such
     Product. Notwithstanding the foregoing, Buyer shall have no rights under
     this Section 4.1 (A) if the third-party quote is given in connection with
     or in anticipation of some other relationship with the Buyer.

     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential
                                                                               6

<PAGE>

B.   If Seller fails to timely deliver *** of the amount of any Product ordered
     by Buyer as required hereunder for any reason, excluding force majeure, as
     measured over any period of ninety (90) or more consecutive days, then
     Buyer may upon twenty (20) days' prior notice to Seller elect to terminate
     Buyer's obligations to purchase, and Seller's obligation to supply, such
     Product hereunder.

              Article 6. TERMINATION, RIGHTS AND OBLIGATIONS UPON
                                  TERMINATION

SECTION 6.1    TERM. Unless terminated for any particular Product pursuant to
Sections 5.1(A) or 5.1(B) hereof or by either party pursuant to the other
provisions of this Article 6, this Agreement shall continue in effect until
three (3) years from the date of First Commercial Sale of the first Product
supplied hereunder (the "Initial Term"), and shall thereafter remain in effect
until terminated by either Party upon at least ninety (90) days prior written
notice to the other Party.

SECTION 6.2    TERMINATION FOR DEFAULT.  If either party materially defaults in
the performance of any material Agreement, condition or covenant of this
Agreement and such default or noncompliance shall not have been remedied, or
steps initiated to remedy the same to the other party's reasonable satisfaction,
within ninety (90) days (or 10 days in the case of non-payment) after receipt by
the defaulting party of a notice thereof from the other party, the party not in
default may terminate this Agreement.

SECTION 6.3    RIGHTS AND OBLIGATIONS ON EXPIRATION OR TERMINATION.  Except to
the extent expressly provided to the contrary, the following provisions shall
survive the termination of this Agreement:  this Section 6.3 and Articles 7
through 10.  Any rights of Seller to payments accrued through termination as
well as obligation of the parties under firm orders for purchase and delivery of
Products at the time of such termination shall remain in effect, except that in
the case of termination under Section 6.2, the terminating party may elect
whether obligations under firm orders will remain in effect, except that Seller
will have no obligation with respect to Delivery Dates more than six (6) months
after termination.

                          Article 7. CONFIDENTIALITY

SECTION 7.1    CONFIDENTIAL INFORMATION.  All Confidential Information disclosed
by a Party to any other Party during the term of this Agreement shall not be
used by the receiving Party except in connection with the activities
contemplated by this Agreement, shall be maintained in confidence by the
receiving Party (except to the extent reasonably necessary for regulatory
approval of products developed by Buyer, Seller or any of their respective
Affiliates), and shall not otherwise be disclosed by the receiving Party to any
other person, firm, or agency, governmental or private, without the prior
written consent of the disclosing Party, except to the extent that the
Confidential Information (as determined by competent documentation):

     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential
                                                                               7
<PAGE>

A.   was known or used by the receiving Party prior to its date of disclosure to
     the receiving Party; or

B.   either before or after the date of the disclosure to the receiving Party is
     lawfully disclosed to the receiving Party by sources other than the
     disclosing Party rightfully in possession of the Confidential Information;
     or

C.   either before or after the date of the disclosure to the receiving Party
     becomes published or generally known to the public (including information
     known to the public through the sale of products in the ordinary course of
     business) through no fault or omission on the part of the receiving Party
     or its sublicensees; or

D.   is independently developed by or for the receiving Party without reference
     to or reliance upon the Confidential Information; or

E.   is required to be disclosed by the receiving Party to comply with
     applicable laws, to defend or prosecute litigation or to comply with
     governmental regulations, PROVIDED THAT the receiving Party provides prior
     written notice of such disclosure to the disclosing Party and takes
     reasonable and lawful actions to avoid and/or minimize the degree of such
     disclosure, PROVIDED THAT, specific information shall not be deemed to be
     within any of these exclusions merely because it is embraced by more
     general information falling within these exclusions.

SECTION 7.2    EMPLOYEE AND ADVISOR OBLIGATIONS.  Seller and Buyer each agree
that they shall provide Confidential Information received from any of the other
Parties only to their respective employees, consultants and advisors, and to the
employees, consultants and advisors of such Party's Affiliates, who have a need
to know and have an obligation to treat such information and materials as
confidential.

SECTION 7.3    COMPETITION.  Seller agrees that for the term or the Agreement
and for a period of three (3) years after the expiration of the Agreement,
Seller shall not share, contract or make available for purposes of sale, any
information, technology, process technology and/or product technology developed
under this Agreement by either party with its customers or potential customers
that are either manufacturers of mass spectrometers or companies that perform or
intend to perform biopolymer analysis using mass spectrometry.

SECTION 7.4    EQUITABLE RELIEF.  Seller acknowledges and agrees that due to the
unique nature of Buyer's Proprietary Information, there can be no adequate
remedy at law for any breach of its obligations hereunder, that any such breach
may allow Seller or third parties to unfairly compete with Buyer resulting in
irreparable harm to Buyer, and therefore, that upon any such breach or threat
thereof, Buyer shall be entitled to injunctions and other appropriate equitable
relief in addition to whatever remedies it may have at law.

SECTION 7.5    TERM.  All obligations of confidentiality imposed under this
Article 7 shall continue for a period of at least five (5) years following
termination or expiration of this Agreement.

Confidential                                                                   8
<PAGE>

                   Article 8. REPRESENTATIONS AND WARRANTIES

SECTION 8.1    REPRESENTATION OF AUTHORITY; CONSENTS.  Seller and Buyer each
represent and warrant to the other Parties that as of the Execution Date it has
full right, power and authority to enter into this Agreement, this Agreement has
been duly executed by such Party and constitutes a legal, valid and binding
obligation of such Party, enforceable in accordance with its terms, and all
necessary consents, approvals and authorizations of all government authorities
and other persons required to be obtained by such Party in connection with the
execution, delivery and performance of this Agreement have been and shall be
obtained.

SECTION 8.2    NO CONFLICT.  Each Party represents to the other Parties that
notwithstanding anything to the contrary in this Agreement, the execution and
delivery of this Agreement and the performance of such Party's obligations
hereunder (a) do not conflict with or violate such Party's Articles of
Incorporation and Bylaws or any requirement of applicable laws or regulations
and (b) do not and shall not conflict with, violate or breach or constitute a
default or require any consent under, any contractual obligation of such Party.

SECTION 8.3    KNOWLEDGE OF PENDING OR THREATENED LITIGATION.  Each Party
represents and warrants to the other Parties that there is no claim,
investigation, suit, action or proceeding pending or, to the knowledge of such
Party, expressly threatened, against such Party before or by any governmental
entity or arbitrator that, individually or in the aggregate, could reasonably be
expected to (i) have a material adverse effect on such Party, (ii) materially
impair the ability of such Party to perform any obligation under this Agreement
or (iii) prevent or materially delay or alter the consummation of any or all of
the transactions contemplated hereby.

SECTION 8.4    EMPLOYEE AND CONSULTANT OBLIGATIONS.  Each Party represents and
warrants that all of its employees, officers, and consultants have executed
agreements or have existing obligations under law requiring, in the case of
employees and officers, assignment to such Party of all inventions made during
the course of and as the result of their association with such Party and, in the
case of employees, officers and consultants, obligating the individual to
maintain as confidential such Party's Confidential Information as well as
confidential information of a third party which such Party may receive, to the
extent required to support such Party's obligations under this Agreement.

SECTION 8.5    FULL DISCLOSURE.  Each Party has disclosed to the other Parties
in good faith, all material information such Party believes is relevant to the
subject matter of this Agreement, and to such Party's ability to observe and
perform its obligations hereunder.

SECTION 8.6    WARRANTIES.  Seller warrants to Buyer that, when shipped to Buyer
by Seller, the Products will conform in all respects to the specifications set
forth in Exhibit I, as then in effect, and (ii) will not be adulterated.
BUYER'S SOLE AND EXCLUSIVE REMEDY FOR ANY BREACH OF THE FOREGOING WARRANTIES OR
FOR PRODUCT DEFECTS SHALL BE ITS RIGHT UNDER SECTIONS 2.6 AND 9.1 HEREOF OR
REPLACEMENT OF OR, AT SELLER'S OPTION OF IF REPLACEMENT IS IMPRACTICAL, REFUND
FOR RETURNED NONCONFORMING UNITS OF PRODUCT PROVIDED TO SELLER WITHIN

Confidential                                                                   9
<PAGE>

THREE (3) MONTHS AFTER THE ORIGINAL NONCONFORMING UNITS (BUT NOT REPLACEMENTS)
ARE SHIPPED BY SELLER. EXCEPT FOR THE FOREGOING WARRANTIES, SELLER DOES NOT
WARRANT THE MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE PRODUCTS
OR THE PERFORMANCE OR NONINFRINGEMENT THEREOF, DOES NOT MAKE ANY WARRANTY,
EXPRESS OR IMPLIED, WITH RESPECT TO PRODUCTS, SPECIFICATIONS, SUPPORT, SERVICE
OR ANYTHING ELSE AND DOES NOT MAKE ANY WARRANTY TO BUYER'S CUSTOMERS OF AGENTS.
SELLER HAS NOT AUTHORIZED ANYONE TO MAKE ANY REPRESENTATION OR WARRANTY OTHER
THAN AS PROVIDED ABOVE. THE FOREGOING LIMITATIONS OF WARRANTIES SHALL NOT IN ANY
WAY LIMIT BUYER'S RIGHTS UNDER SECTION 9.1 THEREOF.

                      Article 9. MISCELLANEOUS PROVISIONS

SECTION 9.1    PRODUCT LIABILITY INDEMNIFICATION.

A.   BUYER.  Buyer agrees to defend Seller and its affiliates at Buyer's cost,
     and will indemnify and hold Seller and their respective directors,
     officers, employees and agents ("the Seller Indemnified Parties") harmless
     from and against any losses, costs, damages, fees or expenses arising out
     of any claim relating to (i) any breach by Buyer of any of their respective
     representations, warranties or obligations pursuant to this Agreement, or
     (ii) personal injury from the use, sale or other disposition of any product
     or service offered by Buyer and/or its respective licensees or
     collaborators.  In the, event of any such claim against the Seller
     Indemnified Parties by any third party, Seller shall promptly notify Buyer
     in writing of the claim and Buyer shall manage and control, at their sole
     expense, the defense of the claim and Buyer shall manage and control, at
     their sole expense, the defense of the claim and its settlement.  The
     Seller Indemnified Parties shall cooperate with Buyer and may, at their
     option and expense, be represented in-any such action or proceeding.  Buyer
     shall not be liable for any litigation costs or expenses incurred by the
     Seller Indemnified Parties without Buyer's prior written authorization.  In
     addition, Buyer shall not be responsible for the indemnification of any
     Seller Indemnified Party arising from any negligent or intentional acts by
     such party.

B.   SELLER.  Seller agrees to defend Buyer and its Affiliates at Seller's cost,
     and will indemnify and hold Buyer and their Affiliates and their respective
     directors, officers, employees and agents (the "Buyer Indemnified Parties")
     harmless from and against any losses, costs, damages, fees or expenses
     arising out of any claim relating to (i) any breach by Seller of any of its
     representations, warranties or obligations pursuant to this Agreement or
     (ii) personal injury from the development or manufacture of an Product.
     Provided however, Seller shall have no indemnity obligations for any
     personal injury claims arising after delivery of the Product to Buyer, or
     arising out of the use or sale of the Product by Seller or its licenses or
     collaborators.  In the event of any claim against the Buyer Indemnified
     Parties by any third party, Buyer shall promptly notify Seller in writing
     of the claim and Seller shall manage and control, at its sole expense, the
     defense of the claim and its settlement.  The Buyer Indemnified Parties
     shall cooperate with Seller and may, at their option and expense, be
     represented in any such action or

Confidential                                                                  10
<PAGE>

     proceeding. Seller shall not be liable for any litigation costs or expenses
     incurred by the Buyer Indemnified Parties without Seller's prior written
     authorization. In addition, Seller shall not be responsible for the
     indemnification of any Buyer Indemnified Party arising from any negligent
     or intentional acts by such party.

SECTION 9.2    GOVERNING LAW.  This Agreement shall be construed and the
respective rights of the Parties hereto determined according to the substantive
laws of the State of California notwithstanding the provisions governing
conflict of laws under such California law to the contrary, except matters of
intellectual property law which shall be determined in accordance with the
national intellectual property laws relevant to the intellectual property in
question.

SECTION 9.3    ASSIGNMENT.  Neither Seller, on one hand, nor Buyer, on the
other hand, may assign this Agreement in whole or in part without the consent of
the other, except if such assignment occurs in connection with the sale or
transfer of all or substantially all of the business and assets of Seller, on
the one hand, or Buyer, on the other, to which the subject matter of this
Agreement pertains.  Notwithstanding the foregoing, any Party may assign its
rights (but not its obligations) pursuant to this Agreement in whole or in part
to an Affiliate of such Party.

SECTION 9.4    AMENDMENTS.  This Agreement constitutes the entire agreement
between the Parties with respect to the subject matter hereof, and supersedes
all previous arrangement with respect to the subject matter hereof, whether
written or oral.  Any amendment or modification to this Agreement shall be made
in writing signed by both Parties.

SECTION 9.5    NOTICES.

     Notices to Buyer shall be addressed to:

     Sequenom, Inc.
     11555 Sorrento Valley Rd
     San Diego, CA 91212-1331

     Attention: Chief Executive Officer
     Facsimile No.: (619) 350-0344

     Notices to Seller shall be addressed to:

     Tactical Fabs, Inc.
     51 Whitney Place
     Freemont, CA 94539

     Attention: Chief Executive Officer
     Facsimile No.: (510) 770-8879

Confidential                                                                  11
<PAGE>

     Any Party may change its address by giving notice to the other Parties in
     the manner herein provided.  Any notice required or provided for by the
     terms of this Agreement shall be in writing, and shall be (a) sent by
     registered or certified mail, return receipt requested, postage prepaid,
     (b) sent via a reputable overnight courier service, or (c) sent by
     facsimile transmission, in each case properly addressed in accordance with
     the paragraph above.  The effective date of notice shall be the actual date
     of receipt by the Party receiving the same.

SECTION 9.6    FORCE MAJEURE.  No failure or omission by the Parties hereto in
the performance of any obligation of this Agreement shall be deemed a breach of
this Agreement or create any liability if the same shall arise from any cause or
causes beyond the control of the Parties, including, but not limited to, the
following: acts of God; acts or omissions of any government; any miles,
regulations or orders issued by any governmental authority or by any officer,
department, agency or instrumentality thereof; fire; storm; flood; earthquake;
accident; war; rebellion; insurrection; riot; and invasion and provided that
such failure or omission resulting from one of the above causes is cured as soon
as is practicable after the occurrence of one or more of the above-mentioned
causes.

SECTION 9.7    PUBLIC ANNOUNCEMENTS.  Any announcements or similar publicity
with respect to the execution of this Agreement shall be agreed upon among the
Parties in advance of such announcement.  All Parties understand that this
Agreement is likely to be of significant interest to investors, analysts and
others, and that any of the Parties therefore may make such public announcements
with respect thereto.  The Parties agree that any such announcement will not
contain confidential business or technical information and, if disclosure of
confidential business or technical information is required by law or regulation,
will make reasonable efforts to minimize such disclosure and obtain confidential
treatment for any such information which is disclosed to a governmental agency
or group.  Each Party agrees to provide to the other Parties a copy of any
public announcement as soon as reasonably practicable under the circumstances
prior to its scheduled release.  Except under extraordinary circumstances, each
Party shall provide the other with an advance copy of any press release at least
five (5) business days prior to the scheduled disclosure.  Each Party shall have
the right to expeditiously review and recommend changes to any announcement
regarding this Agreement or the subject matter of this Agreement.  Except as
otherwise required by law, the Party whose press release has been reviewed shall
remove any information the reviewing Party reasonably deems to be inappropriate
for disclosure.

SECTION 9.8   INDEPENDENT CONTRACTORS.  It is understood and agreed that the
relationship between the Parties hereunder is that of independent contractors
and that nothing in this Agreement shall be construed as authorization for
either Seller, on the one hand, or Buyer, or the other hand, to act as agent for
the other.

SECTION 9.9    NO STRICT CONSTRUCTION.  This Agreement has been prepared jointly
and shall not be strictly construed against any Party.

Confidential                                                                  12
<PAGE>

SECTION 9.10   HEADINGS.  The captions or headings of the sections or other
subdivisions hereof are inserted only as a matter of convenience or for
reference and shall have no effect on the meaning of the provisions hereof.

SECTION 9.11   NO IMPLIED WAIVERS; RIGHTS CUMULATIVE.  No failure on the part
of Seller, on the one hand, or Buyer on the other hand, to exercise, and no
delay in exercising, any right, power, remedy or privilege under this Agreement,
or provided by statute or at law or in equity or otherwise, shall impair,
prejudice or constitute a waiver of any such right, power, remedy or privilege
or be construed as a waiver of any breach of this Agreement or as an
acquiescence therein, nor shall any single or partial exercise of any such
right, power, remedy or privilege preclude any other or further exercise thereof
or the exercise of any other right, power, remedy or privilege.

SECTION 9.12   SEVERABILITY.  If any provision hereof should be held invalid,
illegal or unenforceable in any respect in any jurisdiction, then, to the
fullest extent permitted by law, (a) all other provisions hereof shall remain in
full force and effect in such jurisdiction and shall be liberally construed in
order to carry out the intentions of the Parties as nearly as may be possible
and (b) such invalidity, illegality or unenforceability shall not affect the
validity, legality or enforceability of such provision in any other
jurisdiction.  To the extent permitted by applicable law, Seller and Buyer
hereby waive any provision of law that would render any provision hereof
prohibited or unenforceable in any respect.

SECTION 9.13   EXECUTION IN COUNTERPARTS.  This Agreement may be executed in
counterparts, each of which counterparts, when so executed and delivered, shall
be deemed to be an original, and all of which counterparts, taken together,
shall constitute one and the same instrument.

SECTION 9.14   THIRD PARTY BENEFICIARIES.  No person or entity other than Buyer,
Seller and their respective Affiliates and permitted assignees hereunder shall
be deemed an intended beneficiary hereunder or have any right to enforce any
obligation of this Agreement.

                       Article 10. INTELLECTUAL PROPERTY

SECTION 10.1   INTELLECTUAL PROPERTY.  Seller represents and warrants to Buyer
that as of the Execution Date:

     (i)  it is not aware of any claim made against it asserting the invalidity,
          misuse, unregistrability, unenforceability or non-infringement of any
          of its intellectual property which is the subject of this Agreement
          (the "Intellectual Property") or challenging its right to use or
          ownership of any of the Intellectual Property or making any adverse
          claim of ownership thereof;

     (ii) it is not aware of any pending, or threatened claim or litigation
          which alleges that Seller's activities to date relating to the
          Intellectual Property have violated, or by conducting its business as
          currently proposed to be conducted hereunder would violate, the
          intellectual property rights of any other person;

Confidential                                                                  13
<PAGE>

     (iii) to the best of Seller's knowledge, there has been no infringement or
           misappropriation by a third party of any of the Intellectual
           Property;

     (iv)  to Seller's knowledge, its activities to date have not infringed or,
           by conducting its business as proposed to be conducted hereunder
           would not infringe, any of the intellectual property rights of any
           other person.; and

     (v)   all Seller Process Technology Patent Rights or Seller Product
           Technology Patent Rights are owned by Seller or, to Seller's
           knowledge, are validly licensed to Seller, provided, however, that in
           no event shall this subsection (v) be interpreted as a representation
           or warranty that the Seller Process Technology or Seller Product
           Technology does not infringe or misappropriate intellectual property
           rights of any third party.

SECTION 10.2   PATENT AND PRODUCT RIGHTS.  Title to inventions, developments or
discoveries arising from co-operation conducted under the Supply Agreement shall
be determined in accordance with United States Patent Law, Title 35 United
States Code.

A.   Buyer Inventions - All rights to inventions or discoveries made solely by
     Buyer shall belong to Buyer and shall be disposed of in accordance with
     Buyer policy.

B.   Seller Inventions - All rights to inventions or discoveries made solely by
     Seller shall belong to the Seller and shall be disposed of in accordance
     with Seller policy.

C.   Joint Inventions - All rights to inventions or discoveries made jointly by
     Seller and Buyer shall be jointly-owned.

To the extent that the Seller has the legal right to do so, the Seller shall
offer to the Buyer, in accordance with the provisions of the following
paragraph, a time-limited first right to negotiate a commercial, royalty-bearing
license, to make, use, and sell any Seller or Joint Invention conceived and
first actually reduced to practice in the performance of research under this
Supply Agreement and having an application in *** for the term of any patent
thereon.

The Seller shall disclose to the Buyer any inventions, process technologies and
product technologies arising under this Supply Agreement.  The Buyer shall hold
such disclosure on a confidential basis and will not disclose the information to
any third party without consent of the Seller.

                    Article 11.  EXTENSION OF INITIAL TERM

The Parties acknowledge that they may find it to be mutually beneficial to
continue the relationship established by this Agreement after the termination of
the Initial Term.

     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential                                                                  14
<PAGE>

Consequently, the Parties hereby agree to negotiate in good faith, prior to six
(6) months before the expiration of the Initial Term, whether or not to extend
the Initial Term an terms and conditions that are mutually acceptable to the
Parties.

                       Article 12.  APPROVAL/SIGNATURES

This Agreement shall inure to the benefit of and shall be binding upon the
parties hereto, and their respective successors and permitted assigns.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
by their duly authorized representatives as of the day and year first above
written.

Sequenom, Inc.                               Tactical Fabs, Inc.

By /s/ Hubert Koster                        By /s/ Gerald G. Henderson
   ------------------------------             ---------------------------------
Name (Print)  Hubert Koster, PhD.           Name (Print) Gerald G. Henderson
            ---------------------                       -----------------------
Title President & CEO                       Title President
     ----------------------------                ------------------------------

Confidential                                                                  15
<PAGE>

                        Exhibit I Product Specification

See attached

Confidential                                                                  16
<PAGE>

                                    DIAGRAM

                                      ***
     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential                                                                  17
<PAGE>

                          EXHIBIT II PRODUCT PRICING:

Production cost for the "D" Chip in quantities at die level.

QTY ***                       QTY ***                       QTY ***

    ***                           ***                           ***

Wafers and process to be purchased in *** Shipping will be pre-paid and added.
Payment terms are Net 30 days.

     *** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

Confidential                                                                  18<PAGE>

                                                                EXHIBIT 10.33

                        OEM SUPPLY & LICENSE AGREEMENT

This Agreement made this 15th day of June, 1999 ("Effective Date") is by and
between PerSeptive Biosystems, Inc., a Division of the PE Biosystems Business of
PE Corporation ("PerSeptive"), a Delaware corporation with a place of business
at 500 Old Connecticut Path, Framingham, MA 01701 and Sequenom, Inc.
("Sequenom"), a Delaware corporation with a place of business at 11555 Sorrento
Valley Road, San Diego, CA 92121.

                                   RECITALS

    PerSeptive has expertise in the development and manufacture of mass
spectrometry instrument workstations (the "Mass Spec Products"), and desires to
manufacture and sell to Sequenom Mass Spec Products.

    Sequenom is desirous of purchasing certain Mass Spec Products from
PerSeptive for incorporation into system products to be sold by Sequenom, and in
connection with such sale to obtain from PerSeptive rights to market and resell
PerSeptive's Mass Spec Products to Sequenom's Customers.

    PerSeptive is willing to supply Mass Spec Products to Sequenom and to grant
Sequenom rights to resell such products as part of its system product offering,
all in accordance with the terms and conditions set forth in this Agreement.

    Based on the foregoing recitals and in consideration of the mutual
covenants and promises herein contained, the parties agree as follows:

1.  DEFINITIONS  For purposes of this Agreement and all Exhibits attached
    -----------
hereto, the following terms shall have the meaning set forth below:

    1.1  "Affiliate" means with respect to either Party a person or entity,
    including without limiting the generality of the foregoing, corporations,
    partnerships and joint ventures, that directly or indirectly through one or
    more intermediaries, controls, is controlled by or is under common control
    with such person or entity.  "Control" (and, with correlative meanings, the
    term "controlled by" and "under common control with") means the possession
    of the power to direct or cause the direction of the management and
    policies of such person or entity, whether through the ownership of voting
    stock, by contract or otherwise.  In the case of a corporation, "control"
    shall mean, among other things, the direct or indirect ownership of fifty
    percent (50%) or more of its outstanding voting stock.

    1.2  "Agreement" means this OEM Agreement, as amended from time to time.

    1.3  "Agreement Year" means any twelve month period during the term of this
    Agreement commencing on the Effective Date or any anniversary date thereof.

    1.4  "Backorders" has the meaning set forth in Section 5. 1.

                                       1
<PAGE>

    1.5  "Confidential Information" means all materials, know-how or other
    information, including, without limitation, proprietary information and
    materials (whether or not patentable) regarding a Party's technology,
    products, business information or objectives, which is designated as
    confidential in writing by the disclosing Party, whether by letter or by
    the use of an appropriate stamp or legend, prior to or at the time any such
    material, trade secret or other information is disclosed by the disclosing
    Party to the other Party. Notwithstanding the foregoing to the contrary,
    materials, know-how or other information which is orally, electronically or
    visually disclosed by a Party, or is disclosed in writing without an
    appropriate letter, stamp or legend, shall constitute Confidential
    Information of a Party (a) if the disclosing Party, within thirty (30) days
    after such disclosure, delivers to the other Party a written document or
    documents describing the materials, know-how or other information and
    referencing the place and date of such oral, visual, electronic or written
    disclosure and the names of the persons to whom such disclosure was made,
    or (b) such information is of the type that is customarily considered to be
    confidential information by persons engaged in activities that are
    substantially similar to the activities being engaged in by the Parties
    hereunder. Notwithstanding the foregoing, any technical or financial
    information of a Party disclosed by PerSeptive to Sequenom or visa versa or
    disclosed through an audit or sales report shall constitute Confidential
    Information of a Party unless otherwise specified.

    1.6  "Customer" means the end-user customer who purchases a Sequenom system
    that includes Product(s).

    1.7  "Cutoff period" has the meaning set forth in Section 4.3.

    1.8  "Delivery Date" means the date on which delivery of Product(s) is
    properly requested in a Purchase Order and accepted by PerSeptive.

    1.9  "Discount Recapture" has the meaning set forth in Section 3.3.

    1.10  "Intellectual Property Rights" has the meaning set forth in Section
    4.11.

    1.11  "Invoice" means a PerSeptive in voice issued to Sequenom in
    accordance with the terms of this Agreement.

    1.12  "Party" means Sequenom or PerSeptive; "Parties" means Sequenom and
    PerSeptive.  As used in this Agreement, references to "third parties" means
    persons or entities other than a Party or its Affiliates.

    1.13  "Products" means the current, specific Mass Spec Products identified
    by PerSeptive's part numbers listed on Exhibit 2.1 attached hereto, a
    general description of which is set forth opposite each such part number,
    including the licenses required for the operation of the Products as
    outlined in Section 13.  Products shall also include any such products as
    changed or modified by PerSeptive in a manner that does not substantially
    alter the form, fit or function of any such product.

                                       2
<PAGE>

    1.14  "Projected Quantity" has the meaning set forth in Section 3.2.

    1.15  "Purchase Order" means a Sequenom purchase order issued to PerSeptive
    in accordance with the terms of this Agreement.

    1.16  "Release date" has the meaning set forth in Section 4.3.

    1.17  "Specifications" means information specifying the technical and
    performance criteria for Products that is published in PerSeptive's
    Standard Operating Procedure (SOP) documents in effect on the date Products
    are shipped in response to a Purchase Order.  Upon request, PerSeptive will
    provide such documents to Sequenom under the confidentiality provisions of
    Section 15.

    1.18  "Trademarks" means PerSeptive's trademarks, logos, trade dress, etc.
    which are affixed either to the Products or on the packages/containers in
    which such Products are shipped, or which are included in written materials
    relating to or mentioning the Products.

2.  PRICE
    -----

    2.1  Exhibit 2.1 attached hereto sets forth the current published retail
    prices ("List Price") for the Products and related installation and support
    services and license fees, and the net sales price payable by Sequenom.
    PerSeptive agrees to provide Products and services to Sequenom at prices
    which reflect a discount        ***
         ***            from List Price as more fully set forth in Exhibit 2.1.
    PerSeptive shall provide Sequenom with at least ninety (90) days notice
    of any pricing changes that may occur from time to time during the term of
    this Agreement.  Sequenom shall pay to PerSeptive for each Product ordered
    pursuant to this Agreement an amount equal to the retail list price of such
    Product, as set forth on the Exhibit 2.1 in effect at the time the order is
    received by PerSeptive, less the discount applicable to such Product set
    forth on Exhibit 2. 1.

    2.2  Prices given in Exhibit 2.1 are exclusive of, and Sequenom shall be
    responsible for the payment of, shipping charges (including freight and
    insurance customs fees, installation, field service maintenance and support
    (unless field service occurs within the warranty period), extended
    warranty, as well as any applicable sales, use, service, value added and
    similar taxes.

3.  DISCOUNTS
    ---------

    3.1  To qualify for the discounts set forth in Exhibit 2.1, Sequenom agrees
    to purchase      ***       Products having      ***
          ***      (a "System Product") over the three-year term of this
    Agreement.

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       3
<PAGE>

    3.2  Subject to the provisions of Section 4, on the Effective Date and on
    or before three (3) months prior to the end of an Agreement Year, Sequenom
    will issue a Purchase Order for the number of System Products that Sequenom
    intends to purchase in the coming year.  For each Agreement Year, the
    projected quantity of System Products to be purchased by Sequenom
    ("Projected Quantity") is as follows:

         Year 1    ***  Products
         Year 2    ***  Products
         Year 3    ***  Products

    3.3  To maintain the discount from list price of the Products as set forth
    in Exhibit 2.1, Sequenom must order for delivery in any Agreement Year no
    less than   ***                             ***  of the Projected Quantity
    ("Required Purchases").  If in any Agreement Year Sequenom does not meet its
    quota of Required Purchases, the discount provided Sequenom shall be reduced
    *** *** ***     Such reduction in discount shall remain in effect until such
    time as Sequenom shall have ordered in accordance with the terms of this
    Agreement and released for delivery a sufficient quantity of System Products
    to make up the prior year(s) deficiency(ies) and satisfy the current year's
    pro rata Required Purchases.

    3.4  Notwithstanding the provisions of Section 3.3, and subject to the last
    sentence of this Section 3.4, all Invoices issued with respect to orders
    for delivery placed by Sequenom under this Agreement shall reflect the
    applicable discount set forth in Exhibit 2. 1.  However, the dollar amount
    equal to the Discount Recapture, if any, will be calculated by PerSeptive,
    and notice thereof provided to Sequenom, within forty five (45) days after
    the end of each Agreement Year, with any such amount being carried forward
    from year to year during the term of this Agreement.  At the end of the
    second Agreement Year, PerSeptive will invoice Sequenom for any Discount
    Recapture due, and Sequenom agrees to pay such invoice within thirty (30)
    days of its issuance.  If by the end of the second Agreement Year Sequenom
    has ordered and released for delivery less than *** System Products,
    PerSeptive may in its sole discretion discontinue or modify the discounts
    set forth in Exhibit 2.1 on all future orders placed by Sequenom during the
    term of this Agreement.

    3.5  Notwithstanding any provision to the contrary as may be contained
    herein, if at the end of the third Agreement Year Sequenom shall not have
    ordered and released for delivery   ***  System Products, it shall be
    obligated to purchase from PerSeptive within the next ninety (90) days that
    number of System Products equal to the difference between the number of
    System Products actually ordered by Sequenom and   *** at a fully discounted
    price equal to the discounted price set forth in Exhibit 2.1

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       4
<PAGE>

4.  ORDERS
    ------

    4.1  Orders for the purchase of Products hereunder shall be submitted to
    PerSeptive on a Purchase Order and shall specifically reference this
    Agreement.  All orders are subject to acceptance by PerSeptive, which shall
    not be unreasonably withheld.  All terms and conditions of sale of Products
    are set forth in this Agreement.  In the event of a conflict between the
    terms and conditions of this Agreement and the terms and conditions on a
    Purchase Order or Invoice, the terms and conditions of this Agreement shall
    prevail except for terms of a Purchase Order specifically designated by
    PerSeptive as terms that supercede the inconsistent terms in this
    Agreement.

    4.2  Upon acceptance of a Purchase Order, PerSeptive shall use commercially
    reasonable efforts to manufacture the Products in accordance with the
    Specifications and to ship such Products in accordance with the delivery
    requirements and Delivery Dates set forth in Section 6.

    4.3  Purchase Orders will include the quantities and types of Products to
    be purchased by Sequenom during the coming year together with an estimated
    schedule of when such Products are to be released for delivery ("release
    date").  Except for Products scheduled to be released within a rolling
    three (3) month period from any calendar date (the "cutoff period"),
    Sequenom may adjust the quantity, type and release date of the Products
    listed on the Purchase Order at its discretion.  The quantity and type of
    Products scheduled to be released within the cutoff period can not be
    altered.

    4.4  PerSeptive's supply obligation hereunder will not extend to more that
    ***        *** of Sequenom's Projected Quantity of Products for the year in
    question. If Sequenom's Product requirements for any quarter exceeds *** of
    Sequenom's Projected Quantity of Products, PerSeptive and Sequenom will
    discuss in good faith the additional amount, if any, that PerSeptive is
    willing to supply consistent with its other obligations and Sequenom will
    adjust its order accordingly. Sequenom shall reimburse PerSeptive promptly
    upon request for all reasonable out of pocket costs and expenses, including
    the cost of carrying increased inventory, to the extent caused by any
    deviation in order quantities from the limits imposed by the preceding
    sentence, and PerSeptive will act reasonably to mitigate any such costs and
    expenses.

    4.5  PerSeptive agrees to use its commercially reasonable efforts to
    provide Sequenom with notice ninety (90) days in advance of (i) any changes
    to the Products listed in Exhibit 2.1 that alter the form, fit or function
    of the Product or (ii) the discontinuance of any Product.  PerSeptive
    reserves the right in its sole and absolute discretion to modify the form,
    fit or function of any Product, or to otherwise modify any Product, and to
    discontinue the manufacture of any Product except for Products which have
    been discontinued PerSeptive shall remain obligated to fill orders as have
    been placed by Sequenom that are subject to accepted Purchase Orders.
    Sequenom reserves the right to terminate this contract with no penalty with
    sixty (60) day written notice should the

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       5
<PAGE>

    Products change significantly thereby rendering the Products incompatible
    with Sequenom's products or should the change adversely effect Sequenom's
    ability to sell its products. Notwithstanding any such termination, Sequenom
    shall remain obligated to purchase all Products subject to Purchase Orders
    issued by Sequenom.

    4.6  Sequenom hereby grants to PerSeptive and PerSeptive reserves a
    purchase money security interest in each Product purchased hereunder, and
    in any proceeds thereof, for all amounts owing to PerSeptive for or related
    to the product.  Upon request by PerSeptive, Sequenom shall sign any
    document required for PerSeptive to perfect such security interest.
    Payment in full of the purchase price of any Product purchased hereunder
    shall release the security interest on that Product.

    4.7  PerSeptive shall ship in accordance with PerSeptive's standard
    practices.  Sequenom may specify different shipping instructions, subject
    to agreement by PerSeptive, provided that Sequenom will be subject to an
    additional charge if the alternate method increases the cost of shipping
    equal to the increased cost.

    4.8  Unless otherwise agreed to in writing by PerSeptive, all Products
    shall be packed, if appropriate, for shipment and storage in accordance
    with PerSeptive's standard practices.  All packing shall conform to
    requirements of carrier's tariffs.

    4.9  All Products are subject to PerSeptive's standard tolerances for
    specifications.  PerSeptive reserves the right to make substitutions and
    modifications in the Specification of any Product, provided that such
    substitutions or modifications do not materially affect the performance of
    the Products.

    4.10  All patents, copyrights, trade secrets and other intellectual
    property rights (collectively, "Intellectual Property Rights") in or
    related to the Products sold hereunder are and will remain the exclusive
    property of PerSeptive or its licensors.  Sequenom shall not hereby acquire
    any Intellectual Property Rights in the Products except as expressly set
    forth in this Agreement.

    4.11  PerSeptive does not warrant the validity or enforceability of any
    Intellectual Property Rights relating to any Products.  PerSeptive warrants
    and represents, however, that at the time of the sale it is not aware of
    any infringement of any patents or patent applications or other
    Intellectual Property Rights owned by third parties which would prevent
    Sequenom from using or selling the Products.

    4.12  PerSeptive shall have the sole and exclusive right to evaluate any
    suit, claim or proceeding brought against Sequenom alleging that a Product
    purchased by Sequenom from PerSeptive and sold hereunder infringes any
    Intellectual Property Rights of others and to take any and all legal action
    PerSeptive shall deem appropriate with respect thereto.  PerSeptive will
    pay any cost of damages finally awarded against Sequenom in any such
    action.  Sequenom shall have the right to participate and be represented in
    any such suit by its own counsel at its own expense, but Sequenom shall not
    agree to, and PerSeptive shall have no liability for, any settlement,
    compromise or dismissal of such

                                       6
<PAGE>

    suit, or costs incurred in connection therewith, without PerSeptive's
    consent. Should the use of any Products by Sequenom be enjoined, or if
    PerSeptive believes that the use of the Products may infringe the
    Intellectual Property Rights of others, PerSeptive may, at its option,
    require Sequenom to discontinue the use of the allegedly infringing Product
    and shall either (i) substitute an equivalent non-infringing Product, (ii)
    modify the Product so that it no longer infringes but remains equivalent,
    (iii) obtain for Sequenom, at PerSeptive's own expense, the right to
    continue use of such Product, or (iv) refund the purchase price for such
    Product. At PerSeptive's request, Sequenom shall promptly return the Product
    to PerSeptive, at PerSeptive's expense. The foregoing states the entire
    liability of PerSeptive for Intellectual Property Right infringement.

5.  BACKORDERS
    ----------

    5.1  Backorders are defined as orders for System Products (excluding any
    piece, spare or similar component parts) that have not been fully received
    at the designated delivery point within the guaranteed order lead-time,
    subject to Section 6.1 below.

    5.2  Backorders must show an approximate shipping date and indicate the
    reason for such backorder.

    5.3  PerSeptive is required to provide any backorders without any extra
    service or delivery charges.

    5.4  It is the responsibility of PerSeptive to manage backorders and
    provide Sequenom, at no additional cost, with the required Products
    designated in a Purchase Order and to ensure their timely delivery.

         (i)  In case of default, and after notifying PerSeptive, Sequenom may
    obtain the equivalent Products from other suppliers.

         (ii) PerSeptive will be responsible, for the cost difference between
    the Products and the Products from other suppliers.

    5.5  PerSeptive will be in default if the Products are backordered for more
    than ten (10) working days, or if Sequenom feels that the approximate
    shipping date provided by PerSeptive for the backordered Product(s)
    jeopardizes Sequenom's commercial operations and the operation of its
    Customers.

6.  DELIVERY
    --------

    6.1  PerSeptive shall use commercially reasonable efforts to deliver
    Products to Sequenom on or within five (5) business days after the Delivery
    Dates set forth in Purchase Orders accepted by PerSeptive.  Unless
    PerSeptive otherwise agrees, all Delivery Dates shall be ninety (90) days
    or more from the date the Purchase Order is delivered to PerSeptive.

                                       7
<PAGE>

    6.2  In the event circumstances of force majeure as defined in Section 19.1
    exist which would prevent or delay delivery of Products by PerSeptive,
    PerSeptive shall have the right to apportion Products available for
    delivery among its various customers.

7.  SHIPMENT AND RISK OF LOSS
    -------------------------

    7.1  All Products delivered pursuant to the terms of this Agreement shall
    be F.O.B. PerSeptive manufacturing Plant, freight and insurance prepaid and
    added to the invoice, to Sequenom's address or other place of delivery as
    designated time to time by Sequenom, provided, however, that if delivery is
    requested to a site other than Sequenom's address set forth in Section 18,
    Sequenom shall be responsible to qualify delivery to such other site by
    specifying in sufficient detail to PerSeptive all of the necessary shipping
    and installation requirements for such site.  Sequenom shall indemnify and
    hold PerSeptive harmless, including the reimbursement of all reasonable
    expenses incurred by PerSeptive, as a result of Sequenom's failure to
    properly qualify delivery.  Sequenom shall use its best efforts to assist
    PerSeptive in arranging any desired insurance (in amounts that Sequenom
    shall determine) and transportation, via airfreight unless otherwise
    specified in writing, to any destinations specified in writing from time to
    time.  All customs, duties, costs, taxes, insurance premiums, and other
    expenses relating to such transportation and delivery shall be at
    Sequenom's expense.

    7.2  Title, with the exception of certain technology that is licensed to
    Sequenom as provided in this Agreement, and risk of loss with respect to
    all Products shall pass from PerSeptive to Sequenom upon transfer to the
    carrier.

8.  INSTALLATION AND ACCEPTANCE
    ---------------------------

    8.1  Installation of Products by PerSeptive may be purchased by Sequenom at
    the time of issuance of a Purchase Order by including a statement that
    installation by PerSeptive of the designated Product is requested, or at
    any other time.  If a Purchase Order with installation by PerSeptive
    included is accepted by PerSeptive, PerSeptive shall install the Product,
    in accordance with PerSeptive's then standard installation practice, at the
    Customer location or Sequenom's location, as designated on the Purchase
    Order or as otherwise agreed.  The cost of installation for the Product in
    question will be included on the Purchase Order and may be invoiced by
    PerSeptive with the invoice for the Product, or when installation by
    PerSeptive is otherwise agreed to, may be separately invoiced by
    PerSeptive, at PerSeptive's discretion.  PerSeptive will use commercially
    reasonable efforts to schedule and complete installation in a timely
    fashion.  PerSeptive and Sequenom will cooperate with each other to
    coordinate each other's installation efforts.

    8.2  For Products installed by PerSeptive, PerSeptive shall have no
    obligation to integrate the Product with any product of Sequenom, who shall
    be solely responsible for system integration.

    8.3  For Products installed by PerSeptive, installation shall be complete,
    and acceptance by Sequenom shall occur, when the Product passes
    PerSeptive's standard

                                       8
<PAGE>

    installation and test procedures in effect at the time of installation. For
    Products that are not installed by PerSeptive, acceptance by Sequenom occurs
    upon shipment and will be deemed to have occurred unless Sequenom
    demonstrates within thirty (30) days after delivery that the Product does
    not pass PerSeptive's standard installation and test procedures or satisfy
    the applicable Specifications, in which case acceptance occurs when such
    procedures are passed. Sequenom shall notify PerSeptive in writing of its
    rejection of the Product, specifying in sufficient detail the nature of the
    problem, and shall await PerSeptive's instructions with regard to
    disposition of the rejected Product which shall come no less than forty
    eight (48) hours after receiving the notification. PerSeptive shall use its
    reasonable best efforts to either repair on-site or off site, or, at its
    option, to replace the rejected Product with conforming Product. In any
    event, a Product that passes PerSeptive's standard installation and test
    procedures shall be at the Customer's facility as soon as commercially
    feasible. PerSeptive will use its reasonable commercial efforts to provide a
    Product that passes such tests no later than ten (10) working days after the
    initial Product failed the installation and test procedures. If instructed
    by PerSeptive, and upon receipt by Sequenom of a return authorization from
    PerSeptive, Sequenom shall ship back to PerSeptive any defective Product or
    any component thereof at Sequenom's cost. PerSeptive shall ship any
    replacement product back to Sequenom or the Customer at PerSeptive's cost.
    Refund including any freight and insurance costs incurred for authorized
    returned Products, repair or replacement shall be Sequenom's remedy for any
    rejection of any Product. Products may not be returned to PerSeptive under
    any circumstances without PerSeptive's prior written authorization. Any
    Product not repairable on-site and returned hereunder to PerSeptive may be
    conformed to comply with the Specifications at PerSeptive's facilities and
    thereafter used to fill a future Sequenom order.

9.  TRAINING
    --------

    9.1  PerSeptive commits to train, tuition free, two (2) designated Sequenom
    employees in the installation and routine maintenance of the Products.  The
    training will be conducted concurrently in a single class of two (2) weeks
    duration at PerSeptive's facility as part of PerSeptive's standard training
    programs and will be scheduled and executed within one hundred twenty (120)
    days of the Effective Date.  Sequenom may request from time to time due to
    employee changes or increased customer demand, and PerSeptive shall grant,
    additional training of the type set forth above.  The training will be
    scheduled on a mutually agreed upon basis and shall be invoiced to Sequenom
    at a rate of                        ***

10. PAYMENT
    -------

    10.1  Upon or after delivery of the Product to the F.O.B. point, PerSeptive
    shall submit an Invoice therefor.  Sequenom agrees to pay the amount of
    Invoices submitted by PerSeptive within thirty (30) days from date of
    Invoice.

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       9
<PAGE>

    10.2  If payment is not received by the due date, a service charge may be
    added at the rate of 1.5 % per month (18% per year) or the maximum legal
    rate, whichever is less, to unpaid invoices from the due date thereof.
    Sequenom agrees to pay such service charges and agrees to reimburse
    PerSeptive reasonable attorney's fees and other out of pocket expenses of
    collection if PerSeptive engages counsel and/or incurs expenses to collect
    overdue amounts.

    10.3  In the event that Sequenom shall fail to pay any past due Invoice
    within ten (10) days of receipt of notice from PerSeptive, PerSeptive may,
    at any time and in its sole discretion, limit or cancel the credit of
    Sequenom as to time and amount, and as a consequence, may demand full
    payment or partial payment before delivery of any unfilled Purchase Order
    of this Agreement, and may demand assurance of Sequenom's due performance.
    Upon making such demand, PerSeptive may suspend production, shipment,
    and/or deliveries.  If, within the period stated in such demand, but in no
    event longer than thirty (30) days, Sequenom fails to agree and comply with
    such different terms of payment, and/or fails to give adequate assurance of
    due performance, PerSeptive may (i) by notice to Sequenom, treat such
    failure or refusal as a repudiation by Sequenom of the accepted Purchase
    Orders not then fully performed, whereupon PerSeptive may cancel all
    further deliveries and any amounts unpaid hereunder shall immediately
    become due and payable; or (ii) make shipments under reservation of a
    security interest and demand payment against tender of documents of title.

11. RESALE RESTRICTIONS
    -------------------

    11.1  PerSeptive hereby grants a right to Sequenom to resell the Products,
    bundled with the Sequenom system as described in Section 11.2, only to
    locations      ***
     ***
     ***
     ***
     ***      . If a location other than those listed above is designated as the
    place of installation on a Purchase Order accepted by PerSeptive, the
    parties shall be deemed to have agreed on such other location.

    11.2  It is the intention of the parties that this Agreement represents a
    value added resale business relationship.  Accordingly, Sequenom's resale
    of Products shall be in conjunction with other Sequenom products,
    ***
     ***.  Sequenom shall have no right to resell any Product purchased
    hereunder as a stand-alone Mass Spec Product, and any attempt to do so
    shall be deemed a material breach of this Agreement by Sequenom for which
    there is no right of cure, notwithstanding anything contained in this
    Agreement to the contrary.

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       10
<PAGE>

    11.3  As set forth in Section 15.1, the price of Products payable by
    Sequenom pursuant to this Agreement is Confidential Information of
    PerSeptive, and Sequenom shall not furnish such price in any quote of any
    Sequenom system that includes a Product, or quote other items separately so
    that such price can be deduced, or otherwise disclose such price to any
    third party.

12. WARRANTY
    --------

    12.1  PerSeptive warrants that the Products will conform to the
    Specifications at the time of delivery and will be free from defects in
    materials and workmanship for a period of six (6) months.  The warranty
    period begins on the date of installation if the Products are installed by
    PerSeptive, but in no event later than thirty (30) days after shipment, or
    otherwise on the date of delivery.  The foregoing warranties do not include
    periodic maintenance or calibration recommended for some Products, unless
    specifically covered in the express written warranty terms, if any,
    accompanying the delivery of such Products.  To the extent then generally
    available to PerSeptive customers, Sequenom may purchase extended support
    coverage or a service contract on Products purchased pursuant to this
    Agreement at PerSeptive's then applicable retail rate, less    ***   .

    12.2  If PerSeptive receives notice of defects or nonconformance to the
    Specifications during the warranty period, PerSeptive will, at its option,
    repair (and recalibrate only as necessitated by repairs) or replace the
    affected Products. If PerSeptive is unable, within the times designated in
    Section 12.6, to repair, replace or correct a defect or non-conformance in a
    Product to a condition as warranted, Sequenom will be entitled to a refund
    of the purchase price upon prompt return of the Product to PerSeptive.
    PerSeptive will pay expenses for shipment of both defective and repaired or
    replacement Products.

    12.3  The above warranties do not apply to defects resulting from improper
    or inadequate maintenance or calibration by Sequenom or its Customers;
    Sequenom or third party supplied hardware or software, interfacing or
    supplies; unauthorized modification; improper use or operation outside of
    the Specifications for the Product; abuse, negligence, accident, loss or
    damage in transit; improper site preparation; or unauthorized maintenance
    or repair.

    12.4  Sequenom's sole remedies under PerSeptive's warranty shall be limited
    to repair or replacement of the Product that failed to conform to such
    warranty, or refund of the purchase price of the Product.  Repair,
    replacement or refund shall be at the sole discretion of PerSeptive.

    12.5  THE FOREGOING WARRANTIES ARE EXCLUSIVE AND NO OTHER WARRANTY, EXPRESS
    OR IMPLIED, IS GIVEN BY PERSEPTIVE, INCLUDING THOSE OF MERCHANTABILITY OR
    FITNESS FOR A PARTICULAR PURPOSE, ALL OF WHICH ARE EXPRESSLY DISCLAIMED.

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       11
<PAGE>

    12.6  All Product defects or suspected defects during the warranty period
    will be managed by an authorized Sequenom representative (who has undergone
    training as provided in Section 9) who shall place a call to PerSeptive's
    designated service center followed up with the description of the Product
    problem in sufficient detail as to allow PerSeptive to assess the source of
    the problem.  All service calls placed by Sequenom will be responded to
    either by fax or by phone within two (2) business days with a proposed
    remedy to the Customer's problem being determined by PerSeptive as soon as
    commercially feasible after Sequenom's initial service call.  PerSeptive
    will use its reasonable commercial efforts to see to it that the Customer's
    Product is either fully operational or that a replacement instrument is
    delivered to the Customer if it is determined that an on-site repair is not
    possible with the allotted time within ten (10) business days of the
    initial service call.  Any Product not repairable on-site and returned
    hereunder to PerSeptive may be conformed to comply with the Specifications
    at PerSeptive's facilities and thereafter used to fill a future Sequenom
    order.

13. LICENSE RIGHTS
    --------------

    13.1  The Products purchased pursuant to this Agreement are described and
    claimed in one or more of the following U.S. Patents:
    ***                      , as well as in corresponding foreign patents and
    patent applications        ***        .  The price of each Product includes
    a prepaid royalty of *** of its list price, and in consideration for such
    royalty. PerSeptive hereby grants to Sequenom a non-exclusive license solely
    to use and sell land not to make or have made) the Products with Delayed
    Extraction (TM) technology claimed in the DE Patents and to extend such
    license solely to those Customers of Sequenom who purchase such Product as
    part of a Sequenom system. Any such sublicense extended to its Customers by
    Sequenom as provided herein must incorporate the terms of the license
    provided in this Section 13.1 in a written sublicense agreement acceptable
    to PerSeptive in form and substance, which will be made available to
    PerSeptive upon request. No other license is granted to Sequenom either
    directly or by implication, estoppel or otherwise by PerSeptive under this
    Section 13. 1.

    13.2  PerSeptive represents that it is the exclusive licensee, with the
    right to sublicense, of U.S. Patent Nos. 5,288,644; 5,453,247; and
    5,643,798, and the nonexclusive licensee, with right to sublicense, subject
    to certain rights of the licensor to recapture exclusive rights, of U.S.
    Patent No. 5,045,694 (collectively, the "DNA Patents").  PerSeptive grants
    a non-exclusive sublicense to Sequenom, upon the purchase of the Product,
    to all patent rights (except for rights of manufacture either directly or
    indirectly) in the DNA Patents, thereby providing Sequenom the freedom to
    use, sell and conduct DNA Sequencing and related methods using the Product,
    under the DNA Patents, and to sublicense such rights solely to those
    Customers of Sequenom who purchase such Product as part of a Sequenom
    system. The price of each Product includes a prepaid license fee of ***

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       12
<PAGE>

    per product.  Any sublicense extended to its Customers by Sequenom as
    provided herein must incorporate the terms of the license provided in this
    Section 13.2 in a written sublicense agreement acceptable to PerSeptive in
    form and substance, which will be made available to PerSeptive upon
    request.  No other license is granted to Sequenom either directly or by
    implication, estoppel or otherwise by PerSeptive under this Section 13.2.

    13.3  PerSeptive hereby grants to Sequenom a limited license to use and
    modify the Delayed Extraction technology and the DNA Patents only to the
    extent necessary and solely for the purposes of internal use, testing and
    marketing.

14. TRADEMARKS; PROMOTIONAL MATERIALS
    ---------------------------------

    14.1  PerSeptive hereby grants Sequenom a non-transferable,
    nonsublicensable, nonexclusive license to use the Trademarks, without
    modification unless approved by PerSeptive as set forth in Section 14.2,
    solely in connection with Sequenom with Sequenom marketing, and
    distribution of the Products and Sequenom system.  Sequenom may place its
    own trademarks and brand identification on the Products it purchases
    hereunder provided that (i) Sequenom's trademarks and identification are
    displayed in a size no greater than of those of PerSeptive and (ii)
    Sequenom's trademarks and identification are placed on the Products in a
    manner that is not likely to cause confusion with PerSeptive's trademarks
    and brand identification.

    14.2  Within thirty (30) days of the Effective Date, Sequenom will submit
    for approval by PerSeptive, which shall not be unreasonably withheld, a
    design layout showing the use of Sequenom's trademarks and brand
    identification on the Products.  Any subsequent changes to such layout will
    similarly require PerSeptive's approval.

    14.3  All advertisements and other promotional materials and other
    descriptions of systems that include Products published by Sequenom shall
    include a notation that the Products have been manufactured by PerSeptive
    under agreement with Sequenom and an indication of the applicable license
    rights accompanying the sale of Products as set forth in Sections 13.1 and
    13.2.

15. CONFIDENTIALITY
    ---------------

    15.1  During the term of this Agreement, all Confidential Information
    exchanged or developed under this Agreement shall be kept strictly
    confidential by either party and shall not be used by either party nor
    disclosed by either party to any third party for any purpose except those
    of this Agreement and within either party's own organization only to
    employees or consultants who have undertaken a similar obligation for the
    time during and after the term of their employment or consulting contract.
    This obligation shall not extend to any Confidential Information that is
    now or subsequently becomes part of the public domain through no breach of
    this Agreement.  By way of example but not by way of limitation, all
    information relating to PerSeptive's sale of Products (e.g., price,
    quantity, discount, delivery schedule, Product improvements, SOP documents,
    operation

                                       13
<PAGE>

    manuals, schematics, design specifications, manufacturing procedures, etc.)
    and Specifications shall be deemed PerSeptive's Confidential Information.

    15.2  The provisions of Section 15.1 shall survive any termination of this
    Agreement and continue in force for a period of five (5) years following
    the effective date of any such termination.

16. LIMITATION OF LIABILITY; INDEMNIFICATION
    ----------------------------------------

    16.1  Except solely with respect to damages for personal injury caused by
    PerSeptive's negligence or willful misconduct, PerSeptive's liability
    arising out of this Agreement, including without limitation on account of
    any breaches or default, or from or on account of any Products sold
    pursuant to this Agreement, or the use thereof, arising from whatever
    cause, whether tort, breach of contract, warranty, or otherwise, excepting
    solely fraud, is limited to one million dollars ($1,000,000) in the
    aggregate.  This Section does not limit liability for bodily injury of a
    person.

    16.2  NOTWITHSTANDING ANYTHING CONTAINED IN THIS AGREEMENT TO THE CONTRARY,
    IN NO EVENT SHALL PERSEPTIVE BE LIABLE, WHETHER IN CONTRACT, TORT,
    WARRANTY, OR UNDER ANY STATUTE (INCLUDING WITHOUT LIMITATION ANY TRADE
    PRACTICE, UNFAIR COMPETITION OR OTHER STATUTE OF SIMILAR IMPORT) OR ON ANY
    OTHER BASIS, FOR INDIRECT, PUNITIVE, MULTIPLE, INCIDENTIAL, CONSEQUENTIAL
    OR SPECIAL DAMAGES SUSTAINED BY SEQUENOM OR ANY OTHER PERSON ARISING OUT OF
    OR IN CONNECTION WITH ANY ASPECT OF THIS AGREEMENT OR ITS PERFORMANCE OR
    ANY FAILURE IN PERFORMANCE OR BREACH, OR THE USE OR PERFORMANCE, OR
    CONSEQUENCES OF USE OR PERFORMANCE, OF ANY PRODUCTS MANUFACTURED OR
    FURNISHED BY PERSEPTIVE WHETHER OR NOT FORESEEABLE AND WHETHER OR NOT
    PERSEPTIVE IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGE, INCLUDING, WITHOUT
    LIMITATION, DAMAGES ARISING FROM OR RELATED TO LOSS OF USE, LOSS OF DATA,
    FAILURE OR INTERRUPTION IN THE OPERATION OF ANY EQUIPMENT OR SOFTWARE,
    DELAY IN REPAIR OR REPLACEMENT, OR FOR LOSS OF REVENUE OR PROFITS, LOSS OF
    GOODWILL, OR LOSS OF BUSINESS UNLESS EXPLICITLY PROVIDED FOR HEREIN.

    16.3  Sequenom agree to defend PerSeptive and its Affiliates at its cost
    and expense, and will indemnify and hold PerSeptive, its Affiliates and
    their respective directors, officers, employees and agents (the "PerSeptive
    Indemnified Parties") harmless from and against any liabilities, losses,
    costs, damages, fees or expenses (including reasonable attorney's fees)
    arising out of any claim relating to (i) any breach by Sequenom of any of
    its representations, warranties or obligations pursuant to this Agreement
    or (ii) personal injury or property damage from the use, sale or other
    disposition of any Product or service offered by Sequenom and/or its
    respective licensees or collaborators or (iii)

                                       14
<PAGE>

    the negligence or willful misconduct of Sequenom, except in all cases to the
    extent caused by the negligence or Willful misconduct of PerSeptive.

    16.4  PerSeptive agrees to defend Sequenom and its Affiliates at its cost
    and expense, and will indemnify and hold Sequenom, its Affiliates and their
    respective directors, officers, employees and agents (the "Sequenom
    Indemnified Parties") harmless from and against any liabilities, losses,
    costs, damages, fees or expenses (including reasonable attorney's fees)
    arising out of any claim relating to (i) any breach by PerSeptive of any of
    its representations, warranties or obligations pursuant to this Agreement
    or (ii) personal injury or property damage from the negligent development
    and manufacture of any Product or service offered by PerSeptive or its
    licensees or collaborators or (iii) the negligence or willful misconduct of
    PerSeptive, except in all cases to the extent caused by the negligence or
    willful misconduct of Sequenom.

    16.5  Whenever any claim shall arise for indemnification hereunder, the
    party seeking indemnification (the "Indemnified Party") shall promptly
    notify the party from whom indemnification is sought (the "Indemnifying
    Party").  Such notice shall specify the nature of the claim and, when
    known, the facts constituting the basis for, as well as the amount or an
    estimate of the amount of the liability arising from, such claim.  Failure
    to promptly notify shall not relieve a Party from its indemnity obligations
    hereunder except to the extent of prejudice caused by such failure.  The
    Indemnified Party shall not settle or compromise any claim by a third party
    for which it is entitled to indemnification hereunder without the prior
    written consent of the Indemnifying Party, which shall not be unreasonably
    withheld, unless suit shall have been instituted against it and the
    Indemnifying Party shall not have taken control of such suit after
    notification thereof as provided in Section 16.6.

    16.6  In connection with any claim giving rise to indemnity under Section
    16 of this Agreement, the Indemnifying Party at its sole cost and expense
    may, upon written notice to the Indemnified Party, assume the defense of
    any such claim or legal proceeding if it acknowledges to the Indemnified
    Party in writing its obligations to indemnify the Indemnified Party with
    respect to all elements of such claim.  The Indemnified Party shall be
    entitled to participate in (but not control) the defense of any such
    action, with its counsel and at its own expense.  If the Indemnifying Party
    does not assume the defense of any such claim or litigation resulting
    therefrom within thirty (30) days after the date notice of such claim is
    given, the Indemnified Party may defend against such claim or litigation,
    without prejudice to pursue its rights of indemnity.  In such event, the
    Indemnified Party may defend in a manner as it may deem appropriate,
    including, but not limited to, settling such claim or litigation, but only
    after giving written notice of the same to the Indemnifying Party, on such
    terms as the Indemnified Party may deem appropriate, and the Indemnifying
    Party shall be entitled to participate in (but not control) the defense of
    such action, with its counsel and at its own expense.  The Parties shall
    cooperate with each other in the defense of any such third party claim
    pursuant to this Section 16.

                                       15
<PAGE>

17. TERM AND TERMINATION
    --------------------

    17.1  The term of this Agreement shall be for the period beginning on the
    Effective Date and ending three (3) years thereafter.

    17.2  This Agreement shall terminate upon written notice by one Party to
    the other in the event the other Party shall become insolvent, or shall ask
    its creditors for a moratorium, or shall file a voluntary bankruptcy
    petition, or shall suffer appointment of a temporary or permanent receiver,
    trustee, or custodian, for all or a substantial part of its assets who
    shall not be discharged within sixty (60) days.

    17.3  Either Party may terminate this Agreement for default by the other
    Party to perform any of its obligations under this Agreement by notifying
    the other Party in writing of such default and allowing the other party
    thirty (30) days within which to cure such default, unless the default is
    the failure to pay money, in which case the defaulting party shall have
    only five days to cure such default after receiving written notice of
    nonpayment.  If such default is not cured within thirty (30) days from
    receipt of such notice of default (or five (5) days in the case of non-
    payment of money owed), the non-defaulting party may terminate this
    Agreement by written notice to the defaulting party.

    17.4  Except to the extent expressly provided to the contrary, the
    following provisions shall survive the termination of this Agreement: this
    Section 17.4, Section 15, Section 16, Section 18, and Section 19.  Any
    rights of Seller to payments accrued through termination as well as
    obligation of the parties under firm orders for purchase and delivery of
    Products at the time of such termination shall remain in effect, except
    that in the case of termination under Section 17.3, the terminating party
    may elect whether obligations under firm orders will remain in effect and
    except that PerSeptive will have no obligation to manufacture and deliver
    Products that have Delivery Dates more than six (6) months after the date
    of termination.

18. NOTICES
    -------

    18.1  All notices and requests required or authorized hereunder shall be
    given in writing either by personal delivery; by registered or certified
    mail, return receipt requested; or by fax or telex.  Such notice shall be
    deemed to have been given upon, such date that it is so personally
    delivered; the date three (3) days after it is deposited in the mail; or
    the date the same is received by the receiving party's fax or telex
    machine, irrespective of the date appearing therein.

         If to PerSeptive:                   If to Sequenom:
         PerSeptive Biosystems, Inc.         Sequenom, Inc.
         500 Old Connecticut Path            11555 Sorrento Valley Road, Suite C
         Framingham, MA 01701                San Diego, CA 92121-1331

                                       16
<PAGE>

         Attention: General Counsel          Attention: Business Development
         Tel: (508) 383-7700                 Tel: (619) 350-0345
         Fax: (508) 383-7468                 Fax: (619) 350-0344

19. GENERAL
    -------

    19.1  Force Majeure

    Except with respect to the payment of money, neither party shall be liable
    for any failure or delay in its performance under this Agreement due to
    causes, including, but not limited to, acts of God, acts of civil or
    military authority, fires, epidemics, floods, earthquakes, riots, wars,
    sabotage, labor shortages or disputes, and governmental actions, which are
    beyond its reasonable control; provided that the delayed party: (i) gives
    the other party written notice of such cause and (ii) uses its reasonable
    efforts to correct such failure or delay in its performance.  The delayed
    party's time for performance or cure under this Paragraph 19.1 shall be
    extended for a period equal to the duration of the cause.

    19.2  Relationship of Parties

    The parties to this Agreement are independent contractors.  Neither party
    nor their respective employees, consultants, contractors or agents are
    agents, employees or joint ventures of the other, nor do they have any
    authority to bind the other by contract or otherwise to any obligation.
    Neither party will not represent to the contrary, either expressly,
    implicitly, by appearance or otherwise.

    19.3  Assignment

    Neither PerSeptive, on one hand, nor Sequenom, on the other hand, may
    assign this Agreement in whole or in part without the consent of the other,
    except if such assignment occurs in connection with the sale or transfer of
    all or substantially all of the business and assets of PerSeptive, on the
    one hand, or Sequenom, on the other, to which the subject matter of this
    Agreement pertains.  Notwithstanding the foregoing, any Party may assign
    its rights (but not its obligations) pursuant to this Agreement in whole or
    in part to an Affiliate of such Party.

    19.4  Successors in Interest

    Subject to Section 19.3, the rights and liabilities of the parties hereto
    will bind and inure to the benefit of their respective successors,
    executors and administrators, as the case may be.

    19.5  Applicable Law

    This Agreement shall be governed by and construed in accordance with the
    laws of the Commonwealth of Massachusetts, U.S.A, exclusive of its
    conflicts of law rules.  Any litigation or other dispute resolution between
    the parties relating to this Agreement shall

                                       17
<PAGE>

    take place in the District of Massachusetts. The parties consent to the
    personal jurisdiction of and venue in the state and federal courts within
    that District.

    19.6  Severability

    If for any reason a court of competent jurisdiction finds any provision of
    this Agreement, or portion thereof, to be unenforceable, that provision of
    the Agreement shall be enforced to the maximum extent permissible so as to
    effect the intent of the parties, and the remainder of this Agreement shall
    continue in full force and effect.

    19.7  No Waiver

    Failure by either party to enforce any provision of this Agreement shall
    not be deemed a waiver of future enforcement of that or any other
    provision.

    19.8  Counterparts

    This Agreement may be executed in one or more counterparts, each of which
    will be deemed an original, but all of which will constitute but one and
    the same instrument.

    19.9  Complete Agreement

    This Agreement, including all Exhibits, constitutes the entire agreement
    between the parties with respect to the subject matter hereof, and
    supersedes and replaces all prior or contemporaneous understandings or
    agreements, written or oral, regarding such subject matter.  No amendment
    to or modification of this Agreement shall be binding unless in writing and
    signed by a duly authorized representative of both parties.

    19.10  Third Party Beneficiaries

    No third party beneficiary rights are conferred or are intended to be
    conferred by this Agreement.

    19.11  Headings

    Headings in this Agreement are for convenience only, and shall not be used
    to and shall not effect the meaning or interpretation of this Agreement.

    19.12  Full Disclosure

    Any representations made by the Parties in this Agreement or any Exhibit
    hereto do not contain any untrue statement of a material fact or omit any
    material fact necessary in order to make the statements contained therein
    misleading.

                                       18
<PAGE>

    19.13  Public Announcements

    Any announcements or similar publicity with respect to the execution of
    this Agreement shall be agreed upon among the Parties in advance of such
    announcement.  All Parties understand that this Agreement is likely to be
    of significant interest to investors, analysts and others, and that any of
    the Parties therefore may make such public announcements with respect
    thereto.  The Parties agree that any such announcement will not contain
    confidential business or technical information and, if disclosure of
    confidential business or technical information is required by law or
    regulation, will make reasonable efforts to minimize such disclosure and
    obtain confidential treatment for any such information which is disclosed
    to a governmental agency or group.  Each Party agrees to provide to the
    other Parties a copy of any public announcement as soon as reasonably
    practicable under the circumstances prior to its scheduled release.  Except
    under extraordinary circumstances, each Party shall provide the other with
    an advance copy of any press release at least five (5) business days prior
    to the scheduled disclosure.  Each Party shall have the right to
    expeditiously review and recommend changes to any announcement regarding
    this Agreement or the subject matter of this Agreement.  Except as
    otherwise required by law, the Party whose press release has been reviewed
    shall remove any information the reviewing Party reasonably deems to be
    inappropriate for disclosure.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first indicated above.

PerSeptive Biosystems, Inc.        Sequenom, Inc.

By: /s/ Joseph E. Malandrakis        By: /s/ Hubert Koster
    -------------------------            -------------------------
    Name: Joseph E. Malandrakis          Name: Hubert Koster
    Title: VP/ General Manger            Title: President & CEO

Legal:  A.T. Karnalirs

                                       19
<PAGE>

                                  EXHIBIT 2.1

                      Product Price and Discount Schedule

<TABLE>
<CAPTION>
Part No.                            Description                                  ***          ***          ***
----------------------------------------------------------------------------------------------------------------------
<S>               <C>                                                            <C>          <C>          <C>
V888520           Voyager-DE Biospectrometry Workstation with Data                            ***
                  System*
                               License Fee for DNA Patents
----------------------------------------------------------------------------------------------------------------------
V700454           500 MHz Acquisition System*                                                 ***
----------------------------------------------------------------------------------------------------------------------
V999999           Negative Ion Capability                                                     ***
----------------------------------------------------------------------------------------------------------------------
V700388           Sample Video Monitor System                                                 ***
                  (US, Canada and Japan Only)
----------------------------------------------------------------------------------------------------------------------
V700718           Sample Video Monitor System                                                 ***
                  (EU and rest of world)
----------------------------------------------------------------------------------------------------------------------
V700715           High Current Detector for Voyager-DE
                  (factory installed)
----------------------------------------------------------------------------------------------------------------------
V888630           Voyager-DE PRO Biospectrometry Workstation with Data                        ***
                  System (US Canada and Japan only)*
                              License Fee for DNA Patents
----------------------------------------------------------------------------------------------------------------------
V899630           Voyager-DE PRO Biospectrometry Workstation with Data                        ***
                  System (EU and rest of world)*
                              License Fee for DNA Patents
----------------------------------------------------------------------------------------------------------------------
V725113           2 GHz Acquisition System*                                                   ***
----------------------------------------------------------------------------------------------------------------------
V700400           CID Module                                                                  ***
----------------------------------------------------------------------------------------------------------------------
V700716           High Current Detector for Voyager-DE PRO                                    ***
                  (factory installed)
----------------------------------------------------------------------------------------------------------------------
N/A               Installation for Voyager-DE Workstation**                                   ***
----------------------------------------------------------------------------------------------------------------------
N/A               Installation for Voyager-DE PRO Workstation**                               ***
----------------------------------------------------------------------------------------------------------------------
N/A               Field Labor Support Rate                                                    ***
----------------------------------------------------------------------------------------------------------------------
N/A               Extended Support for Voyager-DE Workstation                                 ***
                              a)  BioMaintenance Plan
                              b)  BioAssurance Plan
                              c)  BioAssurance Plus Plan
----------------------------------------------------------------------------------------------------------------------
N/A               Extended Support for Voyager-DE PRO Workstation                             ***          ***
                              a)  Maintenance Plan
                              b)  BioAssurance Plan
                              c)  BioAssurance Plus Plan
----------------------------------------------------------------------------------------------------------------------
</TABLE>

  * Minimum Required Configuration for System Product
 ** Includes Travel Expenses

*** Portions of this page have been omitted pursuant to a request for
Confidential Treatment and filed separately with the Commission.

                                       20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]